Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

DBV Technologies

DBV Technologies reported $-17179000 in Pre-Tax Profit for its fiscal quarter ending in September of 2022.

Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Amarin AMRN:US USD -14496000 7.72M
Esperion Therapeutics ESPR:US USD -61719000 6.23M
Galectin Therapeutics GALT:US USD -11527000 893K
Halozyme Therapeutics HALO:US USD 52.24M 18.55M
Insmed INSM:US USD -159281000 717K
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
PTC Therapeutics PTCT:US USD -134990000 21.32M
Sarepta Therapeutics SRPT:US USD -512710000 411.4M
Ultragenyx Pharmaceutical RARE:US USD -163477000 10.19M
United Therapeutics UTHR:US USD 291.9M 113.1M